145 related articles for article (PubMed ID: 16122201)
1. Adenosquamous carcinoma of the uterine cervix--adjuvant chemotherapeutic treatment with paclitaxel and carboplatin; a case report.
Radić V; Kukura V; Ciglar S
Eur J Gynaecol Oncol; 2005; 26(4):449-50. PubMed ID: 16122201
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer: long-term results.
Mori T; Hosokawa K; Sawada M; Kuroboshi H; Tatsumi H; Koshiba H; Okubo T; Kitawaki J
Int J Gynecol Cancer; 2010 May; 20(4):611-6. PubMed ID: 20686381
[TBL] [Abstract][Full Text] [Related]
3. Multimodal treatment for glassy cell carcinoma of the uterine cervix.
Nasu K; Takai N; Narahara H
J Obstet Gynaecol Res; 2009 Jun; 35(3):584-7. PubMed ID: 19527406
[TBL] [Abstract][Full Text] [Related]
4. A case of glassy cell carcinoma of the uterine cervix that responded to neoadjuvant chemotherapy with paclitaxel and carboplatin.
Takekuma M; Hirashima Y; Takahashi N; Yamamichi G; Furukawa N; Yamada Y; Takakuwa R; Ito I
Anticancer Drugs; 2006 Jul; 17(6):715-8. PubMed ID: 16917218
[TBL] [Abstract][Full Text] [Related]
5. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
Zhang R; Li B; Bai P; Li HJ; Li SM; Wu LY; Li W
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
[TBL] [Abstract][Full Text] [Related]
6. [Two cases of adenosquamous cell carcinoma of advanced cervical cancer treated by carboplatin-based chemotherapy with peripheral blood stem cell autotransplant].
Takeda S; Ikeba K; Ohkubo T; Yamamoto T; Sodemoto T; Takagi A; Kinoshita K; Suwata J; Maeda H; Suzuki Y; Kimura M
Gan To Kagaku Ryoho; 1997 Jun; 24(8):1013-7. PubMed ID: 9212811
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy with weekly carboplatin and paclitaxel for locally advanced cervical carcinoma.
Mori T; Hosokawa K; Kinoshita Y; Watanabe A; Honjo H
Int J Gynecol Cancer; 2008; 18(1):85-9. PubMed ID: 17587314
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy after lymphadenectomy and neoadjuvant chemotherapy followed by radical vaginal trachelectomy in FIGO stage IB1 cervical cancer.
Gottschalk E; Mangler M; Schneider A; Koehler C; Lanowska M
Fertil Steril; 2011 Jun; 95(7):2431.e5-7. PubMed ID: 21349513
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer treatment in Rwanda: Resource-driven adaptations, quality indicators, and patient outcomes.
DeBoer RJ; Umutoni V; Bazzett-Matabele L; Katznelson E; Nguyen C; Umwizerwa A; Bigirimana JB; Paciorek A; Nsabimana N; Ruhangaza D; Ntasumbumuyange D; Shulman LN; Triedman SA; Shyirambere C
Gynecol Oncol; 2022 Feb; 164(2):370-378. PubMed ID: 34916066
[TBL] [Abstract][Full Text] [Related]
10. Chemoradiation with paclitaxel and carboplatin in high-risk cervical cancer patients after radical hysterectomy: a Korean Gynecologic Oncology Group study.
Lee TS; Kang SB; Kim YT; Park BJ; Kim YM; Lee JM; Kim SM; Kim YT; Kim JH; Kim KT
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):304-10. PubMed ID: 23642625
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel and carboplatin for recurrent or persistent cancer of the cervix.
Sit AS; Kelley JL; Gallion HH; Kunschner AJ; Edwards RP
Cancer Invest; 2004; 22(3):368-73. PubMed ID: 15493357
[TBL] [Abstract][Full Text] [Related]
12. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix.
Lee MY; Wu HG; Kim K; Ha SW; Kim JS; Kim IA; Lee HP
Gynecol Oncol; 2007 Jan; 104(1):95-9. PubMed ID: 16996117
[TBL] [Abstract][Full Text] [Related]
13. A case of glassy cell carcinoma of the uterine cervix effectively responding to chemotherapy with paclitaxel and carboplatin.
Hirashima Y; Kobayashi H; Nishiguchi T; Miura K; Kanayama N
Anticancer Drugs; 2001 Aug; 12(7):627-30. PubMed ID: 11487720
[TBL] [Abstract][Full Text] [Related]
14. A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study.
Sehouli J; Runnebaum IB; Fotopoulou C; Blohmer U; Belau A; Leber H; Hanker LC; Hartmann W; Richter R; Keyver-Paik MD; Oberhoff C; Heinrich G; du Bois A; Olbrich C; Simon E; Friese K; Kimmig R; Boehmer D; Lichtenegger W; Kuemmel S
Ann Oncol; 2012 Sep; 23(9):2259-2264. PubMed ID: 22357252
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant combined paclitaxel and carboplatin chemotherapy for glassy cell carcinoma of the uterine cervix: report of three cases with clinicopathological analysis.
Takahashi Y; Sasaki H; Mogami H; Hamada S; Konishi I
J Obstet Gynaecol Res; 2011 Dec; 37(12):1860-3. PubMed ID: 21955049
[TBL] [Abstract][Full Text] [Related]
16. A phase I study of concurrent weekly carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy as an adjuvant treatment for early-stage cervical cancer patients with positive pelvic lymph nodes.
Mabuchi S; Takahashi R; Isohashi F; Yokoi T; Ito K; Tsutui T; Ogata T; Yoshioka Y; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Sep; 23(7):1279-86. PubMed ID: 23835505
[TBL] [Abstract][Full Text] [Related]
17. Survival of the fetus: cervical cancer and pregnancy, a challenging combination.
Levy L; Meuwly JY; Sarivalasis A; Achtari C; Mathevet P; Herrera FG
Lancet; 2020 Sep; 396(10252):725. PubMed ID: 32891213
[No Abstract] [Full Text] [Related]
18. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
19. Prediction of progression-free survival and response to paclitaxel plus carboplatin in patients with recurrent or advanced cervical cancer.
Hisamatsu T; Mabuchi S; Yoshino K; Fujita M; Enomoto T; Hamasaki T; Kimura T
Int J Gynecol Cancer; 2012 May; 22(4):623-9. PubMed ID: 22343974
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
Papadimitriou CA; Bafaloukos D; Bozas G; Kalofonos H; Kosmidis P; Aravantinos G; Fountzilas G; Dimopoulos MA;
Gynecol Oncol; 2008 Jul; 110(1):87-92. PubMed ID: 18455782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
